These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 7471112)
1. Toxicity of spirogermanium in mice and dogs after iv or im administration. Henry MC; Rosen E; Port CD; Levine BS Cancer Treat Rep; 1980; 64(12):1207-10. PubMed ID: 7471112 [TBL] [Abstract][Full Text] [Related]
2. Toxicity of a quinocarmycin analog, DX-52-1, in rats and dogs in relation to clinical outcome. Mirsalis JC; Schindler-Horvat J; Hill JR; Green CE; Mitoma C; Tomaszewski JE; Tyson CA; Donohue SJ Cancer Chemother Pharmacol; 2003 Mar; 51(3):193-201. PubMed ID: 12655436 [TBL] [Abstract][Full Text] [Related]
3. Phase I trial of spirogermanium given by infusion in a multiple-dose schedule. Budman DR; Schulman P; Vinciguerra V; Degnan TJ Cancer Treat Rep; 1982 Jan; 66(1):173-5. PubMed ID: 7053254 [TBL] [Abstract][Full Text] [Related]
4. Spirogermanium: a new investigational drug of novel structure and lack of bone marrow toxicity. Slavik M; Blanc O; Davis J Invest New Drugs; 1983; 1(3):225-34. PubMed ID: 6678870 [TBL] [Abstract][Full Text] [Related]
5. Phase I clinical trial of spirogermanium. Schein PS; Slavik M; Smythe T; Hoth D; Smith F; Macdonald JS; Woolley PV Cancer Treat Rep; 1980; 64(10-11):1051-6. PubMed ID: 7459890 [TBL] [Abstract][Full Text] [Related]
6. Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance. Glaze ER; Lambert AL; Smith AC; Page JG; Johnson WD; McCormick DL; Brown AP; Levine BS; Covey JM; Egorin MJ; Eiseman JL; Holleran JL; Sausville EA; Tomaszewski JE Cancer Chemother Pharmacol; 2005 Dec; 56(6):637-47. PubMed ID: 15986212 [TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
8. Intramuscular, intravenous and oral levetiracetam in dogs: safety and pharmacokinetics. Patterson EE; Goel V; Cloyd JC; O'Brien TD; Fisher JE; Dunn AW; Leppik IE J Vet Pharmacol Ther; 2008 Jun; 31(3):253-8. PubMed ID: 18471147 [TBL] [Abstract][Full Text] [Related]
9. Preclinical toxicologic evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in mice, dogs, and monkeys. Henry MC; Port CD; Levine BS Cancer Treat Rep; 1980; 64(8-9):855-60. PubMed ID: 6893811 [TBL] [Abstract][Full Text] [Related]
10. Phase II study of spirogermanium in metastatic prostate cancer. Dexeus FH; Logothetis C; Samuels ML; Hossan B Cancer Treat Rep; 1986 Sep; 70(9):1129-30. PubMed ID: 3742495 [No Abstract] [Full Text] [Related]
11. Phase II study of spirogermanium in advanced breast cancer. Kuebler JP; Tormey DC; Harper GR; Chang YC; Khandekar JD; Falkson G Cancer Treat Rep; 1984 Dec; 68(12):1515-6. PubMed ID: 6509457 [No Abstract] [Full Text] [Related]
12. NTP technical report on toxicity studies of urethane in drinking water and urethane in 5% ethanol administered to F344/N rats and B6C3F1 mice. Chan PC Toxic Rep Ser; 1996 Mar; (52):1-91, A1-9, B1-9 passim. PubMed ID: 11803705 [TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284 [TBL] [Abstract][Full Text] [Related]
14. Toxicology and Carcinogenesis Studies of Furan (CAS No. 110-00-9) in F344 Rats and B6C3F1 Mice(Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Jan; 402():1-286. PubMed ID: 12621516 [TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of Nitrofurazone (CAS No. 59-87-0) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1988 Jun; 337():1-183. PubMed ID: 12732899 [TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of Nitrofurantoin (CAS No. 67-20-9) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1989 Sep; 341():1-218. PubMed ID: 12724784 [TBL] [Abstract][Full Text] [Related]
17. Toxicity of cordycepin in combination with the adenosine deaminase inhibitor 2'-deoxycoformycin in beagle dogs. Rodman LE; Farnell DR; Coyne JM; Allan PW; Hill DL; Duncan KL; Tomaszewski JE; Smith AC; Page JG Toxicol Appl Pharmacol; 1997 Nov; 147(1):39-45. PubMed ID: 9356305 [TBL] [Abstract][Full Text] [Related]
18. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin. Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137 [TBL] [Abstract][Full Text] [Related]
19. Preclinical toxicologic study of 2,3-dihydro-1H-imidazo[1,2-b] pyrazole (IMPY) in mice, dogs, and monkeys. Henry MC; Port CD; Rosen E; Levine BS Cancer Treat Rep; 1980; 64(10-11):1031-8. PubMed ID: 7459889 [TBL] [Abstract][Full Text] [Related]
20. Intramuscular administration of a low dose of ACTH for ACTH stimulation testing in dogs. Behrend EN; Kemppainen RJ; Bruyette DS; Busch KA; Lee HP J Am Vet Med Assoc; 2006 Aug; 229(4):528-30. PubMed ID: 16910850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]